Mucosal and plasma prostaglandin E2 in ulcerative colitis

Hepato-Gastroenterology

Volumn 46, Issue 28, 1999, Pages 2338-2342

  Wiercinska Drapalo, Alicja ^a   Flisiak, Robert ^b   Prokopowicz, Danuta ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b NONE

Author keywords

Bowel inflammation; Prostaglandins; Ulcerative colitis

Indexed keywords

PROSTAGLANDIN E2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; DISEASE COURSE; DISEASE MARKER; ENDOSCOPY; ENTERITIS; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; PREDICTION; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; RECTUM BIOPSY; RECTUM MUCOSA; ULCERATIVE COLITIS;

ADULT; AGED; COLITIS, ULCERATIVE; COLONOSCOPY; DINOPROSTONE; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINAL MUCOSA; MALE; MIDDLE AGED; RECTUM;

EID: 0032831238     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Euler AR: Gastroenterology: eicosanoids and the gastrointestinal tract. In: Watkins WD et al (Eds.). Prostaglandins in Clinical Practice. New York: Raven Press, 1989; pp. 97-130.
2. Wilson DE, Kaymakcalan H: Digestive diseases. In: Curtis-Prior PB (Ed.). Prostaglandins: Biology and chemistry of prostaglandins and related eicosanoids. Edinburgh. London, Melbourne, New York: Churchill Livingstone, 1988; pp. 361-374.
3. Rampton DS, Sladen GE, Youlten LFJ: Prostaglandins and ulcerative colitis. Gastroenterology 1980; 78:192.
4. Zifroni A, Treves A, Sachar D, Rachmilewitz D: Prostanoid synthesis by cultured intestinal epithelium mononuclear cells in inflammatory bowel disease. Gut 1983; 24:659-664.
5. Burakoff R, Zhao L, Celifarco AJ, Rose KL, Donovan V, Pothoulakis C, et al: Effects of purified Clostridium difficile toxin A on rabbit distal colon. Gastroenterology 1995; 109:348-354.
6. Casellas F, Papo M, Guarner F, Antolin M, Armengol JR, Malagelada JR: Intraluminal colonic release of immunoreactive tumour necrosis factor in chronic ulcerative colitis. Clin Sci 1994; 90:453-458.
7. Raab Y, Sundberg C, Hallgren R, Knutson L, Gerdin B: Mucosal synthesis and release of prostaglandin E2 from activated eosinophils and macrophages in ulcerative colitis. Am J Gastroenterol 1995; 90:614-620.
8. Schmidt C, Baumeister B, Kipnowski J, Sehiermeyer-Dunkhase B, Vetter H: Alteration of prostaglandin E2 and leukotriene B4 synthesis in chronic inflammatory bowel disease. Hepato-Gastroenterol 1996; 48:1508-1512.
9. Truelove SC: Systemic and local corticosteroid therapy in ulcerative colitis. BMJ 1960; 1:464-470.
10. Meyers S, Sacher DB, Present DH, Janowitz HD: Olsalazine in the treatment of ulcerative colitis among patients intolerant of sulphalazine: a prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Scand J Gastroenterol 1988; 23(Suppl):148:29-35.
11. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275.
12. Flisiak R, Baraona E, Li J, Lieber CS: Effect of ethanol on prostanoid production by liver fat-storing cells. Hepatology 1993; 18:153-159.
13. Borowska A, Sierakowski S, Mackowiak J, Wisniewski K: A prostaglandin-like activity in small intestine and postradiational syndrome. Experientia 1979; 35:1368-1374.
14. Gould SR, Brash AR, Conolly M: Increased prostaglandin production in ulcerative colitis. Lancet 1977; II:98-102.
15. Hendel J, Nielsen OH: Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease. Am J Gastroenterol 1997; 92:1170-1173.
16. Stratton MD, Chandel B, Deshpande Y, Kaminski DL, Li AP, Vernava AM, et al: The effect of Clostridium difficile toxin on colonocyte prostanoid activity. Prostaglandins 1994; 48:367-375.
17. Router BK, Asfaha S, Buret A, Sharkey KA, Wallace JL: Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J Clin Invest 1996; 98:2076-2085.
18. Davies NM: Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine. Dis Colon Rectum 1995; 38:1311-1321.
19. Roediger WE, Millard S: Selective inhibition of fatty acid oxidation in colonocytes by ibuprofen: a cause of colitis? Gut 1995; 36:55-59.
20. Terzioglu T, Yalti T, Tezelman S: The effect of prostaglandin El on experimental colitis in the rat. Int J Colorectal Dis 1997; 12:63-66.
21. Lanza FL, Aspinall RL, Swabb EA, Davis RE, Rack MF, Rubin A: Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Gastroenterology 1988; 95:289-294.
22. Tarnawski A, Stachura J, Ivey KJ, Mach T, Bogdal J: Ethanol induced duodenal lesions in man. Protective effect of prostaglandin. Prostaglandins 1981; 21:147-153.
23. Flisiak R, Prokopowicz D: Effect of misoprostol on the course of acute viral hepatitis B. Hepato-Gastroenterol 1997; 44:1419-1425.
24. Flislak R, Prokopowicz D: Plasma iPGE2 and i6-keto PGF10 in the course of liver cirrhosis. Prostaglandins, 1997; 53:11-20.